Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a -29.083% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a: CC(/C=C/c1ccccc1)=N\NC(=O)CSc1ccccn1
b: COc1ccccc1CNc1nc2nc3c(c(=O)n2[nH]1)CCC3
c: O=c1oc(/C=C/c2ccco2)nc2sc3c(c12)CCC3
d: O=C(CCSc1ccc(Cl)cc1)N1CCN(c2ccc(O)cc2)CC1
Answer: a. CC(/C=C/c1ccccc1)=N\NC(=O)CSc1ccccn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(/C=C/c1ccccc1)=N\NC(=O)CSc1ccccn1
CC(/C=C/c1ccccc1)=N\NC(=O)CSc1ccccn1
N-[(E)-[(E)-4-phenylbut-3-en-2-ylidene]amino]-2-pyridin-2-ylsulfanylacetamide